Provided by Tiger Fintech (Singapore) Pte. Ltd.

Inovio Pharmaceuticals

1.87
-0.0700-3.61%
Volume:484.96K
Turnover:903.64K
Market Cap:68.58M
PE:-0.47
High:1.94
Open:1.94
Low:1.82
Close:1.94
Loading ...

Inovio Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
29 Mar

Inovio Pharmaceuticals Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
25 Mar

Inovio Pharmaceuticals Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
21 Mar

Inovio Pharmaceuticals Inc. Stock Slips 6.7%, Underperforms Competitors

Dow Jones
·
20 Mar

Inovio Pharma Is Maintained at Sector Perform by RBC Capital

Dow Jones
·
19 Mar

Inovio Pharma Price Target Maintained With a $3.00/Share by HC Wainwright & Co.

Dow Jones
·
19 Mar

RBC Capital Sticks to Their Hold Rating for Inovio Pharmaceuticals (INO)

TIPRANKS
·
19 Mar

RBC Cuts Price Target on Inovio Pharmaceuticals to $5 From $6, Keeps Sector Perform, Speculative Risk

MT Newswires Live
·
19 Mar

Inovio Pharmaceuticals Inc (INO) Q4 2024 Earnings Call Highlights: Strategic Advances Amid ...

GuruFocus.com
·
19 Mar

JMP Securities Sticks to Their Buy Rating for Inovio Pharmaceuticals (INO)

TIPRANKS
·
19 Mar

Inovio Pharmaceuticals Reports 2024 Financial Results

TIPRANKS
·
19 Mar

Inovio Pharmaceuticals (INO) Q4 2024 Earnings Call Transcript

Motley Fool Transcribing
·
19 Mar

Inovio Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
19 Mar

Inovio Pharmaceuticals Q4 2024 GAAP EPS $(0.65) Beats $(0.90) Estimate, Sales $117.000K Beat $30.000K Estimate

Benzinga
·
19 Mar

Inovio Pharmaceuticals Inc - on Track to Begin Rolling Submission of Bla in Mid-2025

THOMSON REUTERS
·
19 Mar

Press Release: INOVIO Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights

Dow Jones
·
19 Mar

Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
18 Mar

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
17 Mar

Inovio Pharmaceuticals Inc. Stock Rallies 5.2%, Outperforms Competitors

Dow Jones
·
15 Mar

Inovio Pharmaceuticals Inc expected to post a loss of 84 cents a share - Earnings Preview

Reuters
·
15 Mar